2019
DOI: 10.1097/aln.0000000000002752
|View full text |Cite
|
Sign up to set email alerts
|

Lung Pharmacokinetics of Tobramycin by Intravenous and Nebulized Dosing in a Mechanically Ventilated Healthy Ovine Model

Abstract: Pseudomonasvaeruginosa and other Gram-negative organisms occurs frequently, 1 and is associated with significant morbidity and mortality. 2 Drugs from the aminoglycoside class, such as tobramycin, are recommended for the treatment of ventilator-associated pneumonia 3 and are effective against numerous Gram-negative organisms including P. aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumanii. 4 Despite systemic antibiotic therapy, therapeutic failure is common. 5 One reason for this lack of effect could… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 41 publications
0
17
0
Order By: Relevance
“…In healthy sheep, high and homogeneously distributed tobramycin pulmonary interstitial concentrations are observed 30 min after nebulization followed by a bi-compartmental decrease, and contrasting with low concentrations after intravenous administration [2]. In pneumonia, high antibiotic tissue concentrations are also observed but are heterogeneously distributed, and likely influenced by the aeration loss [6,7].…”
Section: Why and When To Administer Nebulized Aminoglycosides And Colmentioning
confidence: 99%
See 3 more Smart Citations
“…In healthy sheep, high and homogeneously distributed tobramycin pulmonary interstitial concentrations are observed 30 min after nebulization followed by a bi-compartmental decrease, and contrasting with low concentrations after intravenous administration [2]. In pneumonia, high antibiotic tissue concentrations are also observed but are heterogeneously distributed, and likely influenced by the aeration loss [6,7].…”
Section: Why and When To Administer Nebulized Aminoglycosides And Colmentioning
confidence: 99%
“…The main reason for nebulizing aminoglycosides and colistin in VAP is to bypass the alveolar-capillary barrier which offers a severe obstacle to lung penetration following intravenous administration. In comparison to intravenous route, nebulized aminoglycosides and colistin can achieve significantly higher lung tissue concentrations necessary for the effective treatment of VAP due to MDR GNB [1,2]. For colistin, this is achieved with minimal systemic toxicity compared to intravenous administration.…”
Section: Why and When To Administer Nebulized Aminoglycosides And Colmentioning
confidence: 99%
See 2 more Smart Citations
“…In a healthy sheep model, lung concentrations of tobramycin in the ELF obtained by BAL overestimated the interstitial concentrations measured by microdialysis by an average of approximately 10-fold. 31 However, nebulized tobramycin allowed higher antibiotic exposure in the interstitial fluid than the IV route, with peak concentrations more than twice as high, suggesting better efficacy for an antibiotic with concentration-dependent bactericidal effect.…”
Section: Aminoglycosidesmentioning
confidence: 99%